SOFIA (Bulgaria), January 12 (SeeNews) – Pharmaceuticals company Bulgarian Rose-Sevtopolis [BUL:4BJ] said on Monday it has received shareholders' approval to merge into its parent company, drug producer Sopharma [BUL:3JR].